DK1560827T3 - Antiinfektiøse midler - Google Patents
Antiinfektiøse midlerInfo
- Publication number
- DK1560827T3 DK1560827T3 DK03768559.1T DK03768559T DK1560827T3 DK 1560827 T3 DK1560827 T3 DK 1560827T3 DK 03768559 T DK03768559 T DK 03768559T DK 1560827 T3 DK1560827 T3 DK 1560827T3
- Authority
- DK
- Denmark
- Prior art keywords
- compound
- hcv
- inhibiting
- processes
- polymerase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
- Quinoline Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/285,714 US20040097492A1 (en) | 2002-11-01 | 2002-11-01 | Anti-infective agents |
US10/410,853 US20040087577A1 (en) | 2002-11-01 | 2003-04-10 | Anti-infective agents |
US10/625,121 US20040162285A1 (en) | 2002-11-01 | 2003-07-23 | Anti-infective agents |
US10/679,881 US20050075331A1 (en) | 2003-10-06 | 2003-10-06 | Anti-infective agents |
PCT/US2003/034707 WO2004041818A1 (en) | 2002-11-01 | 2003-10-31 | Anti-infective agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1560827T3 true DK1560827T3 (da) | 2011-04-18 |
Family
ID=43426110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03768559.1T DK1560827T3 (da) | 2002-11-01 | 2003-10-31 | Antiinfektiøse midler |
Country Status (6)
Country | Link |
---|---|
JP (2) | JP4738172B2 (de) |
AT (1) | ATE493408T1 (de) |
DE (1) | DE60335564D1 (de) |
DK (1) | DK1560827T3 (de) |
PT (1) | PT1560827E (de) |
SI (1) | SI1560827T1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA100120C2 (en) * | 2007-04-03 | 2012-11-26 | Анадис Фармасьютикалз, Инк. | 5,6-dihydro-1h-pyridin-2-one compounds |
GB0800855D0 (en) * | 2008-01-17 | 2008-02-27 | Syngenta Ltd | Herbicidal compounds |
CN102026990A (zh) * | 2008-04-15 | 2011-04-20 | 因特蒙公司 | 丙型肝炎病毒复制的新颖抑制剂 |
AU2009309837A1 (en) * | 2008-10-29 | 2010-05-06 | Basf Se | Substituted pyridines having a herbicidal effect |
JP2012519661A (ja) * | 2009-03-06 | 2012-08-30 | エフ.ホフマン−ラ ロシュ アーゲー | 抗ウイルス性複素環化合物 |
JP2013525368A (ja) * | 2010-04-23 | 2013-06-20 | キネタ・インコーポレイテツド | 抗ウイルス性化合物 |
MY183704A (en) * | 2011-06-07 | 2021-03-09 | Anadys Pharmaceuticals Inc | [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001261377A1 (en) * | 2000-05-10 | 2001-11-20 | Smith Kline Beecham Corporation | Novel anti-infectives |
AR036081A1 (es) * | 2001-06-07 | 2004-08-11 | Smithkline Beecham Corp | Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos |
WO2003059356A2 (en) * | 2001-10-30 | 2003-07-24 | Smithkline Beecham Corporation | Novel anti-infectives |
-
2003
- 2003-10-31 DE DE60335564T patent/DE60335564D1/de not_active Expired - Lifetime
- 2003-10-31 AT AT03768559T patent/ATE493408T1/de active
- 2003-10-31 SI SI200331953T patent/SI1560827T1/sl unknown
- 2003-10-31 DK DK03768559.1T patent/DK1560827T3/da active
- 2003-10-31 PT PT03768559T patent/PT1560827E/pt unknown
- 2003-10-31 JP JP2005502238A patent/JP4738172B2/ja not_active Expired - Fee Related
-
2011
- 2011-02-18 JP JP2011033491A patent/JP5250649B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP5250649B2 (ja) | 2013-07-31 |
ATE493408T1 (de) | 2011-01-15 |
JP2006509042A (ja) | 2006-03-16 |
SI1560827T1 (sl) | 2011-04-29 |
JP4738172B2 (ja) | 2011-08-03 |
JP2011144183A (ja) | 2011-07-28 |
PT1560827E (pt) | 2011-03-17 |
DE60335564D1 (de) | 2011-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2361913A8 (de) | Antiinfektiöse Mittel | |
WO2007076034A3 (en) | Anti-viral compounds | |
WO2007081517A8 (en) | Anti-viral compounds | |
BR0305259A (pt) | Inibidores de hcv ns5b polimerase | |
BR0309581A (pt) | Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c | |
ATE542826T1 (de) | Inhibitoren des hepatitis-c-virus | |
CO5630024A2 (es) | Compuestos inhibidores de la hepatitis c | |
EE05709B1 (et) | Nukleosiidhend, seda sisaldav farmatseutiline kompositsioon ning hendi kasutamine viiruse RNA-s?ltuva RNA polmeraasi inhibiitorina toimiva ravimi valmistamiseks | |
SG137868A1 (en) | Heterocyclic antiviral compounds | |
EA200900156A1 (ru) | Пиридазиновое соединение (варианты), способ его получения (варианты), способ лечения или профилактики инфекционного вирусного гепатита с с его помощью, композиция и лекарственное средство на его основе | |
HK1122292A1 (en) | Anti-viral compounds | |
HRP20041085B1 (hr) | Inhibitori hepatitis c virusa | |
BRPI0515596A (pt) | composição farmacêutica usada para o tratamento e/ou prevenção de hcv, e, métodos de inibir rna polimerase ns5b de hepatite c de tratar ou prevenir infecção por hepatite c em um mamìfero | |
DE60319820D1 (de) | Pyrazoloä1,5-aüpyrimidin-verbindungen als antivirale agentien | |
ATE522528T1 (de) | Virale inhibitoren | |
BRPI0415883A (pt) | compostos e composições de nucleosìdeo para o tratamento de infecções virais | |
WO2004110351A3 (en) | Heterocyclic compounds for treating hepatitis c virus | |
WO2007092645A3 (en) | Novel hcv inhibitor combinations and methods | |
ATE498398T1 (de) | Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus | |
DK1560827T3 (da) | Antiinfektiøse midler | |
WO2006085141A3 (en) | Compositions and methods for treating or preventing hepadnaviridae infection | |
TW200738707A (en) | Anti-viral compounds | |
IL193113A0 (en) | Heterocyclic antiviral compounds | |
CY1111280T1 (el) | Αντι-μολυσματικοι παραγοντες |